期刊文献+

冠心病患者血清PON-1、ox-LDL水平变化及意义 被引量:1

Changes and significance of serum PON-1 and ox-LDL levels in patients with coronary heart disease
下载PDF
导出
摘要 目的探讨冠心病(CHD)患者血清对氧磷酶-1(PON-1)、氧化低密度脂蛋白(ox-LDL)水平变化及意义。方法回顾性分析168例CHD患者(A组)与同期149例健康体检者(B组)的临床资料。比较CHD患者[缺血性心力衰竭(IHF)、急性心肌梗死(AMI)、不稳定型心绞痛(UAP)、稳定型心绞痛(SAP)、无症状心肌缺血(SMI)](A组)与体检健康者(B组)血清PON-1、ox-LDL水平;比较各类型CHD患者的Gensini积分;分析CHD患者血清PON-1、ox-LDL水平与Gensini积分的相关性。结果各类型CHD患者的血清PON-1水平均低于B组,ox-LDL水平均高于B组(P<0.05);PON-1水平在SMI、SAP、UAP、AMI、IHF组患者中依次降低,ox-LDL水平及Gensini积分依次升高(P<0.05)。各类型CHD患者血清PON-1水平均与Gensini积分呈负相关,ox-LDL水平均与Gensini积分呈正相关(P<0.05)。结论各类型CHD患者血清PON-1水平均降低,而ox-LDL水平及Gensini积分均升高,且各类型CHD患者血清PON-1、ox-LDL水平均与Gensini积分相关。 Objective To investigate the changes and significance of serum paraoxonase-1(PON-1)and oxidized low density lipoprotein(ox-LDL)levels in patients with coronary heart disease(CHD).Methods The clinical data of 168 CHD patients(group A)and 149 healthy persons(group B)were retrospectively analyzed.The levels of serum PON-1 and ox-LDL were compared between CHD patients[ischemic heart failure(IHF),acute myocardial infarction(AMI),unstable angina pectoris(UAP),stable angina pectoris(SAP),silent myocardial ischemia(SMI)](group A)and healthy persons(group B);the Gensini score of all types of CHD patients were compared;the correlation between serum PON-1,ox-LDL levels and Gensini score were analyzed.Results The levels of serum PON-1 in all types of CHD patients were lower than those in the group B,and the levels of ox-LDL were higher than those in the group B(P<0.05);the level of PON-1 in SMI,SAP,UAP,AMI and IHF groups decreased successively,while the level of ox-LDL and Gensini score increased successively(P<0.05).Serum PON-1 level of patients with various types of CHD were negatively correlated with Gensini score,and ox-LDL level were positively correlated with Gensini score(P<0.05).Conclusion The level of serum PON-1 in all types of CHD patients decrease,while the level of ox-LDL and Gensini score increase,and the levels of serum PON-1 and ox-LDL in patients with various types of CHD are correlated with Gensini score.
作者 苏绍红 张俊峰 SU Shaohong;ZHANG Junfeng(Clinical Laboratory Department,the Fifth Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处 《临床医学研究与实践》 2021年第11期28-30,共3页 Clinical Research and Practice
基金 河南省科技计划项目(No.132102310076)。
关键词 冠心病 对氧磷酶-1 氧化低密度脂蛋白 coronary heart disease paraoxonase-1 oxidized low density lipoprotein
  • 相关文献

参考文献9

二级参考文献75

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2052
  • 2杨玉恒,夏岳,戚国庆,原淑鸿,耿玉兰,刘刚,刘坤申.血清对氧磷酶-1活性与冠脉Gensini积分的相关性研究[J].疑难病杂志,2007,6(9):513-515. 被引量:6
  • 3Fihn SD, Gardin JM, Abrams J, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J].Circulation, 2012,126:e354-e471.
  • 4Fihn SD, Gardin JM, Abrams J, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J].Circulation, 2012,126:3097-3137.
  • 5Task force members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology[J].Eur Heart J, 2013,34:2949-3003.
  • 6Qaseem A, Fihn SD, Williams S, et al.Diagnosis of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons[J].Ann Intern Med 2012;157:729-734.
  • 7Tavori H,Aviram M,Khatib S. Paraoxonase 1 protects macrophages from atherogenieity of a specific triglyceride isolated from human carotid lesion[J].Free Radical Bin Med,2011,(01):234-242.
  • 8Yilmaz H,Sayar N,Yilmaz M. Serum paraoxonase 1 activity in women with metabolic syndrome[J].Kardiologia Polska,2010,(11):1219-1224.
  • 9Mackness M,Mackness B. Targeting paraoxonase-1 in atherosclerosis[J].EXPERT OPINION ON THERAPEUTIC TARGETS,2013,(07):829-837.
  • 10Emami Razavi A,Basati G,Varshosaz J. Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome[J].Acta Medica Iranica,2013,(06):365-371.

共引文献260

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部